LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Comprehensive Guide to Hepatitis Advances
- 1st Edition - February 12, 2023
- Editors: Wai-Kay Seto, Mohammed Eslam
- Language: English
- Paperback ISBN:9 7 8 - 0 - 3 2 3 - 9 8 3 6 8 - 6
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 1 3 1 0 - 2
The Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, a… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteThe Comprehensive Guide to Hepatitis Advances provides the most up-to-date information on all types of hepatitis in one resource. Coverage spans hepatitis in all forms (viral, alcoholic, metabolic, drug, autoimmune, etc.), showing the implications of current research in clinical practice and discussing future research directions. Discussions focus on the scientific advancements in understanding the disease process and in the treatment of different groups of hepatitis.
This reference is perfect for basic science researchers in the field of hepatology; practicing gastroenterologists and hepatologists as well as primary care physicians attending to liver disease; and medical residents undergoing specialist training in gastroenterology and hepatology.
- Provides comprehensive coverage of the different types of hepatitis
- Highlights the most recent research findings related to different types of hepatitis and their impact on clinical care
- Discusses future development specific to different types of hepatitis
Practicing Gastroenterologists and Hepatologists and Basic science researchers in the field of Hepatology
Section 1: HEPATITIS: ADVANCES IN CLINICAL EVALUATION
1. Noninvasive assessment of liver disease severity: image-related
2. Noninvasive assessments of liver disease severity based on biomarkers
3. Conventional liver imaging in hepatitis
4. Nutrition in liver disease
Section II: VIRAL HEPATITIS
5. Antivirals against hepatitis viruses: basic mechanisms
6. Hepatitis A and hepatitis E
7. Hepatitis B: epidemiology, natural history, and diagnosis
8. Hepatitis B: treatment
9. Hepatitis C: epidemiology, natural history, and diagnosis
10. Hepatitis C: treatment
11. Hepatitis D
Section III: HEPATITIS: METABOLIC, ALCOHOL, AND DRUG INDUCED
12. Metabolic-associated fatty liver disease: epidemiology, natural history and diagnosis, current paradigm and definitions for MAFLD
13. Metabolic-associated fatty liver disease: pharmacological management
14. Non-pharmacological treatment approach in patients with metabolic dysfunctionassociated liver disease
15. Alcoholic hepatitis
16. Drug-induced liver injury caused by conventional drugs, using cases based on the Roussel Uclaf causality assessment method
17. Introduction to drug-induced liver injury
Section IV: HEPATITIS: CHOLESTATIC, GENETIC, AND AUTOIMMUNE CAUSES
18. Current paradigm and treatment options for autoimmune hepatitis
19. Hereditary hemochromatosis
20. Wilson disease
21. Alpha-1 antitrypsin deficiency
Section V: HEPATITIS: INFECTIONS AND SYSTEMIC CAUSES
22. Hepatitis: infections and systemic causes
23. HIV: hepatic manifestations of HIV and antiretroviral therapy
24. Systemic non-infectious hepatitis
25. Concurrent HCV or fatty liver in patients with chronic hepatitis B virus infection
Section VI: CHILDHOOD AND PREGNANCY
26. Hepatitis during childhood
27. Hepatitis during pregnancy
- No. of pages: 676
- Language: English
- Edition: 1
- Published: February 12, 2023
- Imprint: Academic Press
- Paperback ISBN: 9780323983686
- eBook ISBN: 9780323913102
WS
Wai-Kay Seto
Wai-Kay Seto, MBBS, MD, FRCP, is a Clinical Professor in the Department of Medicine and Principal Investigator of the State Key Laboratory of Liver Research, the University of Hong Kong, Hong Kong. Prof. Seto is currently ranked by Clarivate Analytics in the top 1% worldwide by research. He has published more than 230 international journal articles and book chapters, including leading-authored articles in The Lancet, Journal of Clinical Oncology, Lancet Global Health, Journal of Hepatology, Gut, Hepatology, and Clinical Infectious Diseases, majority related to research on chronic liver diseases. He was part of a Chinese Medical Association expert panel that wrote the first chronic hepatitis B guideline for primary care physicians in Mainland China.
Affiliations and expertise
Clinical Professor, School of Clinical Medicine and State Key Laboratory of Liver Research, The University of Hong Kong, Hong KongME
Mohammed Eslam
Mohammed Eslam, MBBS, MSc, PhD, is a Professor of hepatology in the Storr Liver Centre, Sydney University, and the Head of the genetics and fatty liver group at Storr Liver Centre at the Westmead Institute for Medical Research. He heads the international liver disease genetic consortium. Prof. Eslam is currently ranked by Scival and Expertscape in the top 0.1% worldwide in fatty liver disease research. He has published more than 135 international journal articles and 5 book chapters, including leading-authored articles in the The Lancet, Nature Genetics, Nature Communications, Nature Reviews of Gastroenterology and Hepatology, The Lancet Gastroenterology and Hepatology, Gastroenterology, Gut, Hepatology, and Journal of Hepatology.
Affiliations and expertise
Professor of hepatology, Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, AustraliaRead Comprehensive Guide to Hepatitis Advances on ScienceDirect